PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tracks how well obesity medicines work and how safe they are, without assigning treatment. It is for adults with excess weight or obesity who see a qualified provider with experience treating obesity.
The design is an open-ended prospective observational (non-interventional) registry for subjects living with excess weight or obesity under the care of a qualified provider with documented experience treating patients with obesity
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- The study doctor thinks an approved obesity medicine that works throughout the body is right for you.
- You do not need to start an obesity medicine when you join. If one is prescribed, you must be starting that medicine for the first time.
- You are at least 18 and old enough under local law to agree to join the study.
- You are willing and able to agree to take part.
- You can and will fill out study forms online using your own devices.
- You can and will share your first and last name, email address, language, and main time zone to set up an online account.
- If you live in the US, you can and will share your full legal name, sex at birth, date of birth, and home ZIP code.
Who can't join
- You have type 2 diabetes.
- You are in, or plan to join, a blinded clinical trial—a study where you or the study team do not know which treatment you receive.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: To be eligible to participate in this registry, an individual must meet all of the following criteria: 1. In the opinion of the investigator, the subject is considered a suitable candidate for treatment with a commercially available systemic obesity medication (see Enrollment Eligible Treatments). While subjects do not need to start an obesity medication at the time of registry enrollment, those prescribed a GLP-based or non-GLP-based obesity medication must be initiating the medication for the first time. 2. Is at least 18 years of age or older and has attained the legal age for consent to procedures involved in the research, under the applicable laws of the jurisdiction in which the research is being conducted at the time of enrollment. 3. Is willing and able to consent to participation in the registry. 4. Is willing and able to complete registry-related forms electronically via personal devices 5. Is willing and able to provide first name, last name, email address, language, and primary time zone for electronic data collection account creation. 6. For US subjects only, is willing and able to provide Personally Identifiable Information which includes full legal name, sex at birth, date of birth, and home address zip code. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in the registry: 1. Has Type 2 diabetes (T2D). 2. Is participating or planning to participate in a blinded clinical trial.
Study sites (1)
MA
- CorEvitas, LLC · Waltham, MA 02451Regulatory Corevitas · Study contact · Study contact · corevitasregistrytrials@corevitas.comMore trials in Waltham